Muhammad Aftab
Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aorta, Thoracic | 19 | 2025 | 267 | 3.960 |
Why?
| | Aortic Aneurysm, Thoracic | 14 | 2022 | 131 | 3.360 |
Why?
| | Cardiac Surgical Procedures | 14 | 2023 | 530 | 3.300 |
Why?
| | Blood Vessel Prosthesis Implantation | 12 | 2024 | 202 | 2.450 |
Why?
| | Postoperative Complications | 14 | 2025 | 2654 | 2.260 |
Why?
| | Aortic Aneurysm | 5 | 2020 | 64 | 1.860 |
Why?
| | Hospital Mortality | 14 | 2025 | 911 | 1.810 |
Why?
| | Cardiopulmonary Bypass | 6 | 2020 | 209 | 1.730 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 4 | 2022 | 25 | 1.440 |
Why?
| | Spinal Cord Ischemia | 8 | 2022 | 56 | 1.210 |
Why?
| | Loeys-Dietz Syndrome | 2 | 2019 | 6 | 1.210 |
Why?
| | Endovascular Procedures | 7 | 2018 | 312 | 1.200 |
Why?
| | Thrombocytopenia | 2 | 2020 | 200 | 1.120 |
Why?
| | Heart Valve Prosthesis Implantation | 4 | 2017 | 180 | 1.050 |
Why?
| | Acute Kidney Injury | 5 | 2025 | 815 | 1.040 |
Why?
| | Aortic Valve | 8 | 2020 | 351 | 1.040 |
Why?
| | Vascular Surgical Procedures | 4 | 2019 | 303 | 0.990 |
Why?
| | Spinal Cord | 6 | 2019 | 370 | 0.980 |
Why?
| | Paraplegia | 5 | 2022 | 60 | 0.930 |
Why?
| | Heart Transplantation | 6 | 2023 | 754 | 0.920 |
Why?
| | Extracorporeal Membrane Oxygenation | 4 | 2025 | 301 | 0.900 |
Why?
| | Heart Valve Diseases | 4 | 2020 | 151 | 0.900 |
Why?
| | Thoracic Surgery | 8 | 2020 | 132 | 0.890 |
Why?
| | Spinal Cord Injuries | 4 | 2021 | 212 | 0.860 |
Why?
| | Intraoperative Neurophysiological Monitoring | 2 | 2021 | 21 | 0.830 |
Why?
| | Aorta | 7 | 2019 | 417 | 0.820 |
Why?
| | Shock, Cardiogenic | 2 | 2020 | 63 | 0.760 |
Why?
| | Dissection | 3 | 2020 | 52 | 0.720 |
Why?
| | Blood Transfusion | 2 | 2020 | 325 | 0.670 |
Why?
| | Diazoxide | 5 | 2021 | 22 | 0.660 |
Why?
| | Kidney Failure, Chronic | 3 | 2025 | 570 | 0.650 |
Why?
| | Aortitis | 1 | 2019 | 10 | 0.630 |
Why?
| | Spinal Cord Stimulation | 1 | 2019 | 8 | 0.620 |
Why?
| | Politics | 1 | 2020 | 98 | 0.620 |
Why?
| | Perfusion | 3 | 2022 | 213 | 0.600 |
Why?
| | Humans | 72 | 2025 | 137585 | 0.590 |
Why?
| | Aortic Valve Insufficiency | 1 | 2018 | 47 | 0.590 |
Why?
| | Creatinine | 1 | 2020 | 499 | 0.580 |
Why?
| | Stroke | 4 | 2024 | 1120 | 0.560 |
Why?
| | Middle Aged | 31 | 2025 | 33479 | 0.560 |
Why?
| | Ochronosis | 1 | 2017 | 1 | 0.560 |
Why?
| | Alkaptonuria | 1 | 2017 | 2 | 0.550 |
Why?
| | Erythropoietin | 4 | 2018 | 95 | 0.540 |
Why?
| | Length of Stay | 6 | 2020 | 1215 | 0.530 |
Why?
| | Oral Submucous Fibrosis | 1 | 2016 | 2 | 0.510 |
Why?
| | Intraoperative Complications | 1 | 2017 | 138 | 0.500 |
Why?
| | Retrospective Studies | 23 | 2025 | 15657 | 0.490 |
Why?
| | Treatment Outcome | 18 | 2022 | 10811 | 0.490 |
Why?
| | Heart Diseases | 1 | 2019 | 346 | 0.490 |
Why?
| | Mouth Mucosa | 1 | 2016 | 92 | 0.480 |
Why?
| | Cardiomyopathies | 1 | 2019 | 350 | 0.470 |
Why?
| | Aged | 22 | 2025 | 23961 | 0.450 |
Why?
| | Aortic Rupture | 1 | 2014 | 25 | 0.450 |
Why?
| | Viscera | 1 | 2014 | 17 | 0.450 |
Why?
| | Career Choice | 5 | 2016 | 219 | 0.440 |
Why?
| | Aortic Valve Stenosis | 1 | 2017 | 229 | 0.440 |
Why?
| | Internship and Residency | 7 | 2020 | 1147 | 0.440 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 445 | 0.430 |
Why?
| | Male | 42 | 2025 | 67762 | 0.430 |
Why?
| | Risk Assessment | 10 | 2024 | 3457 | 0.430 |
Why?
| | Ischemia | 3 | 2021 | 409 | 0.420 |
Why?
| | Reperfusion Injury | 3 | 2021 | 279 | 0.410 |
Why?
| | Prognosis | 7 | 2020 | 4030 | 0.410 |
Why?
| | Time Factors | 11 | 2020 | 6828 | 0.400 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 350 | 0.400 |
Why?
| | Female | 35 | 2025 | 73304 | 0.380 |
Why?
| | Incidence | 4 | 2020 | 2804 | 0.380 |
Why?
| | Coronary Artery Disease | 3 | 2025 | 698 | 0.360 |
Why?
| | Cardiovascular Diseases | 2 | 2023 | 2111 | 0.350 |
Why?
| | Patient Selection | 4 | 2019 | 696 | 0.340 |
Why?
| | Risk Factors | 12 | 2025 | 10388 | 0.320 |
Why?
| | Neurons | 2 | 2020 | 1590 | 0.310 |
Why?
| | Hypothermia, Induced | 2 | 2022 | 80 | 0.310 |
Why?
| | Propensity Score | 3 | 2019 | 294 | 0.310 |
Why?
| | Receptors, Erythropoietin | 2 | 2018 | 20 | 0.290 |
Why?
| | Cerebrovascular Circulation | 3 | 2022 | 243 | 0.270 |
Why?
| | Heart-Assist Devices | 3 | 2019 | 552 | 0.270 |
Why?
| | Comorbidity | 3 | 2020 | 1622 | 0.260 |
Why?
| | Kidney | 1 | 2014 | 1468 | 0.250 |
Why?
| | Aortic Diseases | 2 | 2019 | 119 | 0.250 |
Why?
| | Adult | 21 | 2025 | 37929 | 0.250 |
Why?
| | Multivariate Analysis | 3 | 2020 | 1509 | 0.240 |
Why?
| | Reoperation | 3 | 2018 | 573 | 0.240 |
Why?
| | Specialties, Surgical | 2 | 2016 | 75 | 0.230 |
Why?
| | Coronary Artery Bypass | 2 | 2025 | 234 | 0.230 |
Why?
| | Neuromuscular Blocking Agents | 1 | 2025 | 26 | 0.230 |
Why?
| | Intensive Care Units | 2 | 2020 | 827 | 0.220 |
Why?
| | Elective Surgical Procedures | 1 | 2025 | 179 | 0.210 |
Why?
| | Organ Preservation Solutions | 1 | 2023 | 45 | 0.210 |
Why?
| | Primary Graft Dysfunction | 1 | 2023 | 32 | 0.210 |
Why?
| | Anastomosis, Surgical | 3 | 2019 | 153 | 0.200 |
Why?
| | Kaplan-Meier Estimate | 4 | 2019 | 889 | 0.190 |
Why?
| | Follow-Up Studies | 4 | 2019 | 5131 | 0.190 |
Why?
| | Heart Valve Prosthesis | 1 | 2023 | 114 | 0.180 |
Why?
| | Replantation | 2 | 2018 | 31 | 0.180 |
Why?
| | Databases, Factual | 3 | 2025 | 1357 | 0.180 |
Why?
| | Survival Rate | 4 | 2019 | 1972 | 0.180 |
Why?
| | Education, Medical, Graduate | 2 | 2016 | 486 | 0.170 |
Why?
| | Tissue and Organ Procurement | 2 | 2022 | 321 | 0.170 |
Why?
| | Stents | 3 | 2022 | 527 | 0.170 |
Why?
| | Vascular Grafting | 1 | 2020 | 13 | 0.170 |
Why?
| | Surgeons | 2 | 2023 | 297 | 0.170 |
Why?
| | Heart Arrest, Induced | 2 | 2017 | 31 | 0.170 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2019 | 179 | 0.170 |
Why?
| | Surveys and Questionnaires | 7 | 2020 | 5778 | 0.170 |
Why?
| | Cardiovascular Abnormalities | 1 | 2020 | 13 | 0.170 |
Why?
| | Subclavian Artery | 1 | 2020 | 28 | 0.170 |
Why?
| | Age Factors | 2 | 2020 | 3295 | 0.160 |
Why?
| | Beauty | 1 | 2020 | 19 | 0.160 |
Why?
| | Carotid Artery, Common | 1 | 2020 | 36 | 0.160 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2020 | 43 | 0.160 |
Why?
| | Decision Support Techniques | 1 | 2024 | 421 | 0.160 |
Why?
| | Mice, Inbred C57BL | 6 | 2021 | 5757 | 0.160 |
Why?
| | Critical Care | 1 | 2025 | 601 | 0.160 |
Why?
| | Mitral Valve | 1 | 2020 | 88 | 0.160 |
Why?
| | Marfan Syndrome | 2 | 2017 | 41 | 0.150 |
Why?
| | Acidosis | 1 | 2020 | 101 | 0.150 |
Why?
| | Prosthesis Failure | 1 | 2020 | 123 | 0.150 |
Why?
| | United States | 8 | 2020 | 14841 | 0.150 |
Why?
| | Prosthesis-Related Infections | 1 | 2020 | 95 | 0.150 |
Why?
| | Ultrasonography, Interventional | 1 | 2020 | 141 | 0.150 |
Why?
| | Morbidity | 1 | 2020 | 324 | 0.150 |
Why?
| | Postoperative Period | 1 | 2020 | 342 | 0.150 |
Why?
| | Device Removal | 1 | 2020 | 136 | 0.150 |
Why?
| | Age Distribution | 1 | 2019 | 392 | 0.150 |
Why?
| | Machine Learning | 1 | 2024 | 493 | 0.150 |
Why?
| | Heart Arrest | 1 | 2022 | 339 | 0.150 |
Why?
| | Sex Distribution | 1 | 2019 | 375 | 0.150 |
Why?
| | Early Diagnosis | 1 | 2020 | 242 | 0.150 |
Why?
| | Pacemaker, Artificial | 1 | 2020 | 119 | 0.150 |
Why?
| | Thrombectomy | 1 | 2019 | 69 | 0.150 |
Why?
| | Sepsis | 1 | 2025 | 617 | 0.150 |
Why?
| | Acute Disease | 3 | 2017 | 1007 | 0.150 |
Why?
| | Reimbursement Mechanisms | 1 | 2019 | 85 | 0.150 |
Why?
| | Nerve Growth Factor | 1 | 2018 | 30 | 0.150 |
Why?
| | Vena Cava, Inferior | 1 | 2019 | 71 | 0.150 |
Why?
| | Nervous System Diseases | 1 | 2021 | 266 | 0.150 |
Why?
| | Substance Abuse, Intravenous | 1 | 2019 | 115 | 0.150 |
Why?
| | Heart Atria | 1 | 2019 | 137 | 0.140 |
Why?
| | Risk | 1 | 2020 | 912 | 0.140 |
Why?
| | Reactive Oxygen Species | 1 | 2020 | 622 | 0.140 |
Why?
| | Catheterization | 1 | 2018 | 179 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 270 | 0.140 |
Why?
| | Apoptosis | 2 | 2018 | 2553 | 0.140 |
Why?
| | Multidetector Computed Tomography | 1 | 2017 | 39 | 0.140 |
Why?
| | Terminally Ill | 1 | 2017 | 37 | 0.140 |
Why?
| | Tracheostomy | 1 | 2019 | 133 | 0.140 |
Why?
| | Administration, Oral | 2 | 2018 | 816 | 0.130 |
Why?
| | Nicorandil | 3 | 2021 | 11 | 0.130 |
Why?
| | Mice | 9 | 2021 | 17787 | 0.130 |
Why?
| | Neuroprotection | 1 | 2017 | 42 | 0.130 |
Why?
| | Population Surveillance | 1 | 2020 | 482 | 0.130 |
Why?
| | Job Satisfaction | 2 | 2016 | 218 | 0.130 |
Why?
| | Prosthesis Design | 1 | 2019 | 327 | 0.130 |
Why?
| | STAT3 Transcription Factor | 1 | 2018 | 206 | 0.130 |
Why?
| | Neuroprotective Agents | 1 | 2018 | 131 | 0.130 |
Why?
| | Defibrillators, Implantable | 1 | 2020 | 315 | 0.130 |
Why?
| | Regional Blood Flow | 2 | 2019 | 474 | 0.130 |
Why?
| | Mitral Valve Insufficiency | 1 | 2017 | 68 | 0.130 |
Why?
| | Coronary Vessels | 1 | 2018 | 248 | 0.120 |
Why?
| | Lung Transplantation | 1 | 2019 | 313 | 0.120 |
Why?
| | Respiration, Artificial | 1 | 2020 | 645 | 0.120 |
Why?
| | Aneurysm, Infected | 1 | 2015 | 4 | 0.120 |
Why?
| | Heart Failure | 2 | 2019 | 2236 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.120 |
Why?
| | Thrombosis | 1 | 2019 | 371 | 0.120 |
Why?
| | Fibrosis | 1 | 2018 | 552 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 364 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 580 | 0.120 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1946 | 0.120 |
Why?
| | Clinical Competence | 3 | 2020 | 1118 | 0.110 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 2031 | 0.110 |
Why?
| | Renal Circulation | 1 | 2014 | 58 | 0.110 |
Why?
| | Blood Vessel Prosthesis | 3 | 2022 | 127 | 0.110 |
Why?
| | Echocardiography | 1 | 2017 | 642 | 0.110 |
Why?
| | Mitochondria | 1 | 2020 | 948 | 0.110 |
Why?
| | Logistic Models | 2 | 2019 | 2074 | 0.100 |
Why?
| | Chi-Square Distribution | 1 | 2014 | 530 | 0.100 |
Why?
| | Biomarkers | 2 | 2025 | 4149 | 0.100 |
Why?
| | Cohort Studies | 5 | 2025 | 5742 | 0.100 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 1040 | 0.100 |
Why?
| | Perception | 1 | 2015 | 359 | 0.100 |
Why?
| | Renal Insufficiency | 1 | 2014 | 162 | 0.090 |
Why?
| | Animals | 9 | 2021 | 36940 | 0.090 |
Why?
| | RNA, Long Noncoding | 1 | 2014 | 181 | 0.090 |
Why?
| | Smoking | 1 | 2019 | 1627 | 0.090 |
Why?
| | Societies, Medical | 1 | 2016 | 820 | 0.090 |
Why?
| | Body Mass Index | 1 | 2020 | 2389 | 0.090 |
Why?
| | Odds Ratio | 1 | 2014 | 1070 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 455 | 0.090 |
Why?
| | Up-Regulation | 3 | 2018 | 843 | 0.090 |
Why?
| | Chronic Disease | 1 | 2017 | 1793 | 0.090 |
Why?
| | Hypertension | 1 | 2020 | 1295 | 0.090 |
Why?
| | Diabetes Mellitus | 1 | 2019 | 1040 | 0.090 |
Why?
| | Analgesics, Opioid | 1 | 2019 | 1000 | 0.090 |
Why?
| | Learning | 1 | 2015 | 409 | 0.090 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2828 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2014 | 596 | 0.090 |
Why?
| | Renal Dialysis | 1 | 2014 | 435 | 0.080 |
Why?
| | Decision Making | 1 | 2017 | 900 | 0.080 |
Why?
| | Survival Analysis | 3 | 2019 | 1325 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2014 | 712 | 0.080 |
Why?
| | Cells, Cultured | 1 | 2017 | 4193 | 0.080 |
Why?
| | Diverticulitis | 1 | 2009 | 8 | 0.080 |
Why?
| | Sigmoid Diseases | 1 | 2009 | 12 | 0.080 |
Why?
| | Colostomy | 1 | 2009 | 28 | 0.080 |
Why?
| | Disease Models, Animal | 4 | 2021 | 4295 | 0.080 |
Why?
| | Intestinal Perforation | 1 | 2009 | 46 | 0.080 |
Why?
| | Colectomy | 1 | 2009 | 100 | 0.070 |
Why?
| | Brain | 1 | 2020 | 2668 | 0.070 |
Why?
| | Kidney Transplantation | 1 | 2014 | 708 | 0.070 |
Why?
| | Melanoma | 1 | 2014 | 760 | 0.070 |
Why?
| | Operative Time | 2 | 2019 | 145 | 0.070 |
Why?
| | Aortography | 2 | 2019 | 52 | 0.070 |
Why?
| | Young Adult | 3 | 2020 | 13209 | 0.070 |
Why?
| | Physicians | 1 | 2015 | 910 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 5472 | 0.060 |
Why?
| | Laparoscopy | 1 | 2009 | 466 | 0.060 |
Why?
| | Quality of Life | 1 | 2016 | 2892 | 0.050 |
Why?
| | Organ Preservation | 1 | 2023 | 102 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2014 | 7635 | 0.050 |
Why?
| | Death | 1 | 2022 | 119 | 0.040 |
Why?
| | Monitoring, Intraoperative | 1 | 2021 | 56 | 0.040 |
Why?
| | Signal Transduction | 3 | 2020 | 5079 | 0.040 |
Why?
| | KATP Channels | 1 | 2021 | 20 | 0.040 |
Why?
| | Potassium Channels | 1 | 2021 | 151 | 0.040 |
Why?
| | Resource Allocation | 1 | 2020 | 52 | 0.040 |
Why?
| | Surgical Instruments | 1 | 2020 | 51 | 0.040 |
Why?
| | Collateral Circulation | 1 | 2019 | 19 | 0.040 |
Why?
| | Suture Techniques | 1 | 2020 | 122 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2021 | 491 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2020 | 205 | 0.040 |
Why?
| | Axillary Artery | 1 | 2018 | 12 | 0.040 |
Why?
| | Brachiocephalic Trunk | 1 | 2018 | 11 | 0.040 |
Why?
| | Echocardiography, Transesophageal | 1 | 2019 | 96 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 1020 | 0.040 |
Why?
| | Constriction, Pathologic | 1 | 2019 | 245 | 0.040 |
Why?
| | Linear Models | 1 | 2020 | 849 | 0.040 |
Why?
| | Disease Progression | 2 | 2016 | 2757 | 0.040 |
Why?
| | Drug Synergism | 1 | 2018 | 382 | 0.030 |
Why?
| | Postoperative Care | 1 | 2019 | 261 | 0.030 |
Why?
| | Sternotomy | 1 | 2016 | 26 | 0.030 |
Why?
| | Adolescent | 3 | 2023 | 21513 | 0.030 |
Why?
| | Vasodilator Agents | 1 | 2018 | 331 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 2018 | 263 | 0.030 |
Why?
| | Thoracoscopy | 1 | 2016 | 56 | 0.030 |
Why?
| | Nitric Oxide | 1 | 2021 | 915 | 0.030 |
Why?
| | Professional Autonomy | 1 | 2016 | 30 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2019 | 1316 | 0.030 |
Why?
| | Blotting, Western | 1 | 2018 | 1226 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2015 | 62 | 0.030 |
Why?
| | Patient Safety | 1 | 2019 | 314 | 0.030 |
Why?
| | Ohio | 1 | 2015 | 152 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2018 | 1353 | 0.030 |
Why?
| | Diacylglycerol O-Acyltransferase | 1 | 2014 | 5 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2018 | 534 | 0.030 |
Why?
| | Heart | 1 | 2018 | 655 | 0.030 |
Why?
| | Carnitine | 1 | 2014 | 84 | 0.030 |
Why?
| | Phosphorylation | 1 | 2018 | 1759 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 322 | 0.030 |
Why?
| | Employment | 1 | 2015 | 178 | 0.030 |
Why?
| | Forecasting | 1 | 2015 | 389 | 0.030 |
Why?
| | Insulin | 1 | 2023 | 2409 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2014 | 510 | 0.020 |
Why?
| | Recovery of Function | 1 | 2017 | 653 | 0.020 |
Why?
| | RNA Interference | 1 | 2014 | 469 | 0.020 |
Why?
| | Triglycerides | 1 | 2014 | 524 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 622 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1639 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2014 | 518 | 0.020 |
Why?
| | Surgical Staplers | 1 | 2009 | 4 | 0.020 |
Why?
| | Surgical Stomas | 1 | 2009 | 7 | 0.020 |
Why?
| | Fat Necrosis | 1 | 2009 | 9 | 0.020 |
Why?
| | Intraoperative Period | 1 | 2009 | 59 | 0.020 |
Why?
| | Blood Loss, Surgical | 1 | 2009 | 101 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2014 | 2475 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 3412 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 2691 | 0.010 |
Why?
| | Feasibility Studies | 1 | 2009 | 956 | 0.010 |
Why?
|
|
Aftab's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|